Evidence map›Paper›PMID 32733646›Full record

ArticleOncotarget2020

Novel role for the Golgi membrane protein TMEM165 in control of migration and invasion for breast carcinoma.

Pavitra Murali, Blake P Johnson, Zhongpeng Lu, Leslie Climer, Danielle A Scott, Francois Foulquier, Gabriela Oprea-Ilies, Vladimir Lupashin, Richard R Drake, Karen L Abbott

Abstract read
In one paragraph

Article in Oncotarget, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. The Golgi as a "Proton Sink" in Cancer.Frontiers in cell and developmental biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pavitra MuraliUniversity of Oklahoma Health Sciences Center, Department of Biochemistry and Molecular Biology, Oklahoma City, OK, United States.
Blake P JohnsonOuchita Baptist University, Department of Biology, Arkadelphia, AR, United States.
Zhongpeng LuUniversity of Oklahoma Health Sciences Center, Department of Biochemistry and Molecular Biology, Oklahoma City, OK, United States.
Leslie ClimerUniversity of Arkansas for Medical Sciences, Department of Biophysics and Physiology, Little Rock, AR, United States.
Danielle A ScottDepartment of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, SC, United States.
Francois FoulquierCentre National de la Recherche Scientifique, Unité Mixte de Recherche, Unité de Glycobiologie Structurale et Fonctionnelle, University of Lille, Lille, France.
Gabriela Oprea-IliesEmory University, Pathology and Laboratory Medicine, Atlanta, GA, United States.
Vladimir LupashinUniversity of Arkansas for Medical Sciences, Department of Biophysics and Physiology, Little Rock, AR, United States.
Richard R DrakeDepartment of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, SC, United States.
Karen L AbbottUniversity of Oklahoma Health Sciences Center, Department of Biochemistry and Molecular Biology, Oklahoma City, OK, United States.

Funding

Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Wade Williams · 2018 to 2026
$27.1M
Proteomics CoreP30DK123704 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DON C. ROCKEY · 2020 to 2026
$8.8M
Characterization of mammalian COG complex-interacting intra-Golgi trafficking macR01GM083144 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI VLADIMIR V LUPASHIN · 2008 to 2026
$6.5M
Glycomics Laboratory for the Development of Ovarian Cancer BiomarkersU01CA226055 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI ABBOTT, KAREN L. · 2018 to 2022
$3.3M
Glycomics Laboratory for the Early Detection of Epithelial Ovarian CancerU01CA168870 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI ABBOTT, KAREN L. · 2012 to 2016
$2.0M
NCI NIH HHS P30 CA225520NCI NIH HHS U01 CA168870NCI NIH HHS U01 CA226055NIDDK NIH HHS P30 DK123704NIGMS NIH HHS R01 GM083144
6 · The paper itself

Abstract

The

Indexed as

breast cancerglycosylationinvasionmigrationTMEM165

Identifiers

PMID32733646
PMCPMC7367651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.